AAAAAA
Results:
1-13
|
Results: 13
Authors:
Heinzerling, L
Lechleider, RJ
Citation: L. Heinzerling et Rj. Lechleider, Hormesis and the law, HUM EXP TOX, 20(3), 2001, pp. 154-155
Authors:
Verrecchia, F
Vindevoghel, L
Lechleider, RJ
Uitto, J
Roberts, AB
Mauviel, A
Citation: F. Verrecchia et al., Smad3/AP-1 interactions control transcriptional responses to TGF-beta in apromoter-specific manner, ONCOGENE, 20(26), 2001, pp. 3332-3340
Authors:
Parks, WT
Frank, DB
Huff, C
Haft, CR
Martino, J
Meng, XW
de Caestecker, MP
McNally, JG
Reddi, A
Taylor, SI
Roberts, AB
Wang, TW
Lechleider, RJ
Citation: Wt. Parks et al., Sorting nexin 6, a novel SNX, interacts with the transforming growth factor-beta family of receptor serine-threonine kinases, J BIOL CHEM, 276(22), 2001, pp. 19332-19339
Authors:
Wurthner, JU
Frank, DB
Felici, A
Green, HM
Cao, ZH
Schneider, MD
McNally, JG
Lechleider, RJ
Roberts, AB
Citation: Ju. Wurthner et al., Transforming growth factor-beta receptor-associated protein 1 is a Smad4 chaperone, J BIOL CHEM, 276(22), 2001, pp. 19495-19502
Authors:
Larisch, S
Yi, YS
Lotan, R
Kerner, H
Eimerl, S
Parks, WT
Gottfried, Y
Reffey, SB
de Caestecker, MP
Danielpour, D
Book-Melamed, N
Timberg, R
Duckett, CS
Lechleider, RJ
Steller, H
Orly, J
Kim, SJ
Roberts, AB
Citation: S. Larisch et al., A novel mitochondrial septin-like protein, ARTS, mediates apoptosis dependent on its P-loop motif, NAT CELL BI, 2(12), 2000, pp. 915-921
Authors:
Larisch-Bloch, S
Danielpour, D
Roche, NS
Lotan, R
Hsing, AY
Kerner, H
Hajouj, T
Lechleider, RJ
Roberts, AB
Citation: S. Larisch-bloch et al., Selective loss of the transforming growth factor-beta apoptotic signaling pathway in mutant NRP-154 rat prostatic epithelial cells, CELL GROWTH, 11(1), 2000, pp. 1-10
Authors:
Kim, RH
Wang, D
Tsang, M
Martin, J
Huff, C
de Caestecker, MP
Parks, WT
Meng, XW
Lechleider, RJ
Wang, TW
Roberts, AB
Citation: Rh. Kim et al., A novel Smad nuclear interacting protein, SNIP1, suppresses p300-dependentTGF-beta signal transduction, GENE DEV, 14(13), 2000, pp. 1605-1616
Authors:
de Caestecker, MP
Yahata, T
Wang, D
Parks, WT
Huang, SX
Hill, CS
Shioda, T
Roberts, AB
Lechleider, RJ
Citation: Mp. De Caestecker et al., The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain, J BIOL CHEM, 275(3), 2000, pp. 2115-2122
Authors:
Yahata, T
de Caestecker, MP
Lechleider, RJ
Andriole, S
Roberts, AB
Isselbacher, KJ
Shioda, T
Citation: T. Yahata et al., The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the Smad transcription factors, J BIOL CHEM, 275(12), 2000, pp. 8825-8834
Authors:
Roberts, AB
de Caestecker, MP
Lechleider, RJ
Citation: Ab. Roberts et al., Signaling from TGF-beta receptors, CANC DRUG, 5, 2000, pp. 39-51
Authors:
Yang, X
Letterio, JJ
Lechleider, RJ
Chen, L
Hayman, R
Gu, H
Roberts, AB
Deng, CX
Citation: X. Yang et al., Targeted disruption of SMAD3 results in impaired mucosal immunity and diminished T cell responsiveness to TGF-beta, EMBO J, 18(5), 1999, pp. 1280-1291
Authors:
Xu, RH
Lechleider, RJ
Shih, HM
Hao, CF
Sredni, D
Roberts, AB
Kung, HF
Citation: Rh. Xu et al., Functional analysis of human Smad1: Role of the amino-terminal domain, BIOC BIOP R, 258(2), 1999, pp. 366-373
Authors:
Vindevoghel, L
Lechleider, RJ
Kon, A
de Caestecker, MP
Uitto, J
Roberts, AB
Mauviel, A
Citation: L. Vindevoghel et al., SMAD3/4-dependent transcriptional activation of the human type VII collagen gene (COL7A1) promoter by transforming growth factor beta, P NAS US, 95(25), 1998, pp. 14769-14774
Risultati:
1-13
|